CD274 and neoplasm: As the PD-L1/PD-1 pathway is known to inhibit antitumor T cell-mediated immune responses, tumor antigen-specific T cells were co-cultured with the Tca8113 cells pretreated with inflammatory cytokines or PHA-supernatant.